Rohto: Discovering new factors in atopic dermatitis: Drug discovery to prevent onset
ROHTO Pharmaceutical: Research results
Severity of Japanese atopic dermatitis: KPRP genotype found to be significantly correlated
Skin of patients with atopic dermatitis: KPRP expression is decreased.
It was suggested that KPRP interacts with components involved in cell-cell adhesion.
⇒Prevents the onset and severity of atopic dermatitis by enhancing the stratum corneum barrier function on the skin surface via KPRP.
Future prospects:
This time, KPRP has been identified as a new factor that may be associated with the severity of atopic dermatitis.
By enhancing the stratum corneum barrier function on the skin surface via KPRP, it is possible to prevent atopic dermatitis from becoming serious and preventing its onset.
Rohto Pharmaceutical Co., Ltd.